Carolyn Bahnck-Teets

Statistics

Publications

Citations

176

H-Index

Active since

2016

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

United States Military Academy

Carolyn Bahnck-Teets is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, antiviral drug design, and medicinal chemistry.

Publications per year

2016–2024

Publications

Design and Synthesis of Piperazine Sulfonamide Cores Leading to Highly Potent HIV-1 Protease Inhibitors

Christopher J. Bungard, Peter Williams, Jürgen Schulz et al. · ACS Medicinal Chemistry Letters · 2017 · 44 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Intact Human Immunodeficiency Virus (HIV) Reservoir Estimated by the Intact Proviral DNA Assay Correlates With Levels of Total and Integrated DNA in the Blood During Suppressive Antiretroviral Therapy

Emmanouil Papasavvas, Livio Azzoni, Brian N. Ross et al. · Clinical Infectious Diseases · 2020 · 31 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17

Discovery of MK-8718, an HIV Protease Inhibitor Containing a Novel Morpholine Aspartate Binding Group

Christopher J. Bungard, Peter Williams, Jeanine Ballard et al. · ACS Medicinal Chemistry Letters · 2016 · 28 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +15

Invention of MK-7845, a SARS-CoV-2 3CL Protease Inhibitor Employing a Novel Difluorinated Glutamine Mimic

Valerie W. Shurtleff, M. E. Layton, Craig A. Parish et al. · Journal of Medicinal Chemistry · 2024 · 28 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

A Phenotypic Screen Identifies Potent DPP9 Inhibitors Capable of Killing HIV-1 Infected Cells

Keith P. Moore, Adam G. Schwaid, Matthew Tudor et al. · ACS Chemical Biology · 2022 · 27 citations

Medicine, Medicinal Chemistry, Pharmacology +16

1–5 of 6